Pastāsti draugiem par šo preci:
Coronavirus Drug Discovery: Volume 3: Druggable Targets and In Silico Update - Drug Discovery Update Elsevier Science
Pasūtīts no attālās noliktavas
Mūsu klienti saka:
Coronavirus Drug Discovery: Volume 3: Druggable Targets and In Silico Update - Drug Discovery Update
Elsevier Science
Coronavirus Drug Discovery, Volume 3: Druggable Targets and In Silico Update is the third of three volumes presenting comprehensive information on drug discovery against COVID-19. The chapters in part one of this volume describe the various druggable targets and associated signaling pathways for effective targeting of SARS-CoV-2. In part two, chapters discuss the various computational approaches and in silico studies against SARS-CoV-2. Written by global team of experts, this book is an excellent resource that will be extremely useful to drug developers, medicinal chemists, pharmaceutical companies in R& D, research institutes in both academia and industry, and the National Library of Medicines and Health. Also, agencies such as the National Institutes of Health, Centers for Disease Control and Prevention, World Health Organization, European Medicines Agency, the US Food and Drug Administration, and all others involved in drug discovery against COVID-19 will find this book useful.
406 pages
| Mediji | Grāmatas Paperback Book (Grāmata ar mīksto vāku un līmēto muguru) |
| Izlaists | 2022. gada 12. jūlijs |
| ISBN13 | 9780323955782 |
| Izdevēji | Elsevier - Health Sciences Division |
| Lapas | 406 |
| Izmēri | 150 × 220 × 10 mm · 539 g |
| Valoda | Angļu |
| Redaktors | Egbuna, Chukwuebuka (Chukwuemeka Odumegwu Ojukwu University, Nigeria.) |
